Pediatric anesthesia & critical care

Current anesthesia practice for preterm infants undergoing surgery for necrotizing enterocolitis: A European survey

J Clin AnesthPublished Cross-sectional study

Authors' conclusion

Anesthesia practice for infants undergoing surgery for NEC was highly variable. Most respondents considered the provided anesthetic care for patients with NEC adequate, but also recognized opportunities for further improvement, especially with regards to monitoring, protocols, and interdisciplinary collaboration.

Study context

Population
Anesthesiologists working in European centers where surgery for necrotizing enterocolitis (NEC) is performed
Participants
173 participants · 31 countries
Outcome
Anesthesia practice
Methodological detailssurvey, multinational (Europe)
  • Survey
  • Multinational (Europe)

Main finding

As reported in the abstract

Written standard protocol for anesthetic care in infants
approximately a third
Screened all patients with NEC preoperatively
Three quarters
Structural preoperative multidisciplinary consultation
a third
Induction: intravenous anesthesia
n = 73, 43%
Induction: combined intravenous and inhalation anesthesia
n = 57, 33%
Intravenous induction agent: propofol
n = 58, 44%
Intravenous induction agent: midazolam
n = 43, 33%
Intravenous induction agent: esketamine
n = 42, 32%
Maintenance: inhalation agents solely
n = 71, 41%
Maintenance: inhalation agents in combination
n = 37, 22%
Considered their anesthetic care for NEC adequate
Sixty percent (n = 104)

Observational data: associations, not effects.

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Current anesthesia practice for preterm infants undergoing surgery for necrotizing enterocolitis: A European survey. J Clin Anesth. Published 5 June 2024. doi:10.1016/j.jclinane.2024.111508

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.